Valiance Clinical Research | Huntington Park

Research site

About

At Valiance Clinical Research, we’re redefining what clinical trials can be—where scientific excellence meets compassion, and every study begins with integrity. Founded by physicians and researchers determined to put patients first, we combine deep medical expertise with a personal, transparent approach that accelerates innovation without losing the human touch.

Location

7305 Pacific Boulevard, Huntington Park, California, United States of America

Website

https://www.Valianceclinicalresearch.com

Site insights

Top conditions

Top treatments

LY3298176

Dapagliflozin

AZD4144

Trevogrumab

QCZ484

Tirzepatide

AR882

Zibotentan

CLS-628

Parent organization

This site is a part of Valiance Clinical Research

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Contact this site

Jesse Padilla

Verified by this site

Active trials

9 of 10 total trials

A Randomized Comparison of Personalized Therapy Mgmt Based On Coronary Atherosclerotic Plaque Vs. Usual Care for Symptomatic Patients With Suspicion of CAD (PARAMOUNT)

PARAMOUNT is a prospective randomized open-label trial testing the hypothesis that a personalized management strategy in symptomatic patients with su...

Enrolling

Coronary Artery Disease

Device: Cleerly Labs and Cleerly ISCHEMIA

A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events (TRANSFORM)

TRANSFORM is a prospective, randomized, open blinded endpoint (PROBE), event-driven, pragmatic trial in patients who are at increased risk for athero...

Enrolling

Diabetes Mellitus, Type 2

Metabolic Syndrome

Device: The Cleerly CAD Staging System

A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity (SURMOUNT-MMO)

This study will investigate the effect of tirzepatide on the reduction of morbidity and mortality in adults living with obesity and provide additiona...

Active, not recruiting

Overweight

Obesity

Drug: Placebo

Drug: Tirzepatide

A Study to Assess Adverse Events and Effectiveness of IntraVenous Infusions of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD) (ANCHOR)

Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the most common genetic cause of kidney disease that causes fluid-filled cysts to develop in...

Enrolling

Autosomal Dominant Polycystic Kidney Disease

Drug: ABBV-CLS-628

Drug: Placebo

A Study to Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive Patients

The purpose of this study is to evaluate the efficacy, safety and tolerability of QCZ484 or placebo, given subcutaneously, every 6 months, at differe...

Enrolling

Hypertension

Drug: QCZ484

Other: Saline

A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult Patients With Obesity for Weight Loss, Fat Loss, and Lean Mass Preservation (COURAGE)

This study is researching experimental drugs called trevogrumab and garetosmab (called "study drugs") in combination with another drug, semaglutide (...

Active, not recruiting

Obesity

Drug: Matching Placebo-Trevogrumab

Drug: Matching Placebo-Garetosmab

Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-302)

This study will assess the serum uric acid lowering effect and safety of AR882 in gout patients at two doses compared to placebo over 12 months

Active, not recruiting

Gout Chronic

Arthritis, Gouty

Drug: AR882 75 mg

Drug: Placebo

Study to Investigate Efficacy, Safety, and Tolerability of Zibotentan/Dapagliflozin Compared to Dapagliflozin in Participants With Chronic Kidney Disease and High Proteinuria (ZENITH High Proteinuria)

This is a Phase III, randomised, multicentre, double-blinded study to evaluate efficacy, safety and tolerability of treatment with zibotentan/dapagli...

Active, not recruiting

Chronic Kidney Disease With High Proteinuria

Drug: Dapagliflozin

Drug: Zibotentan/Dapagliflozin

ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation

This study is conducted to see if ziltivekimab reduces the risk of having cardiovascular events (for example heart attack and stroke) in people with...

Active, not recruiting

Chronic Kidney Disease

Inflammation

Drug: Placebo (Ziltivekimab B)

Drug: Placebo (Ziltivekimab C)